Great post @Eqz, thank you!
From my reading Zotal have been in the business of med-tech & diagnostics for 30 years in Israel. I think seeing the 6 month time frame for approvals from the Israeli ministry of health & reimbursement arrangements probably turned some off. It was only meant to be 1 month for Italy and I think we are getting close to that now. 1 in 8 adults in Israel have diabetes and an aging population, that’s huge. Israel also keep a register for all patients with ESRD & on dialysis, it’s law & it looks like it’s a serious public health problem in that country:
https://www.health.gov.il/English/Topics/KHealth/diabetes/Pages/default.aspx
The way I see it, 2 distribution deals in a month, where will the next country be?
GLTAH
Ann: Middle East is next market for PromarkerD immunoassay test, page-17
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
0.015(1.57%) |
Mkt cap ! $127.0M | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | 99.5¢ | 96.3¢ | $64.34K | 65.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 15200 | 96.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 98.0¢ | 22247 | 2 |
View Market Depth
| Last trade - 15.58pm 16/07/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |